Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02508948 · ClinicalTrials.gov registry record
Endotracheal Intubation Among the Critically Ill: HEMAIR Pilot Study
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 1,288
- Enrollment target
NCT02508948: Completed study, sponsored by Mayo Clinic.
NCT02508948 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 1,288 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02508948 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 1,288 participants
- Enrollment target
Study Summary
In order to examine the current endotracheal intubation practice among critically ill patients, a prospective observational multicenter study of adult critically ill patients was conducted from July 2015 to January 2017 involving 20 ICUs. In this study, the primary aim was to describe, through a prospective observational multicenter study, the current intubation practice of adult critically ill patients undergoing endotracheal intubations with a focus on deriving and validating a prediction model for both immediate airway and hemodynamic complications.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,288 participants |
| Start Date | 2015-08 |
| Est. Completion | 2019-12 |
What the finished NCT02508948 record still lists
NCT02508948 is an observational study that tracks outcomes without assigning an intervention. Its 1,288 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT02508948 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02508948 about?
NCT02508948 is a clinical study titled "Endotracheal Intubation Among the Critically Ill: HEMAIR Pilot Study". In order to examine the current endotracheal intubation practice among critically ill patients, a prospective observational multicenter study of adult critically ill patients was conducted from July 2015 to January 2017 involving 20 ICUs. In this study, the primary aim was to describe, through a pro...
What is the current status of trial NCT02508948?
This trial is currently completed. The enrollment target is 1,288 participants. The study started on 2015-08. Estimated completion is 2019-12.
Who is sponsoring clinical trial NCT02508948?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05595642 · 1,290 participants · Phase 3
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
- NCT06626022 · 1,284 participants · Phase 3
Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging.
- NCT05812807 · 1,295 participants · Phase 3
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
- NCT03970447 · 1,280 participants · Phase 2
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia